Coronavirus
Moderna COVID-19 vaccine 2.0: Lower dose, fewer side effects
Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.
Mass vaccination experiment was a huge success in Brazil
A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.
Inhaled nanobodies treat COVID-19 in hamsters
An inhaled nanobody treatment for COVID-19 has shown promise in animal tests and could be a more affordable alternative to monoclonal antibody drugs.
One-minute COVID-19 breath test authorized in Singapore
Singapore has provisionally authorized a COVID-19 breath test that measures VOCs to deliver accurate results in just one minute.
Inhaled CRISPR treatment tackles COVID-19, flu
An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.
Predicting your protection against COVID-19
Australian researchers have found an immune response measurement they believe can predict protection against COVID-19.
Ohio announces $1M vaccine lottery, shots surge 33%
Ohio’s vaccine lottery, which will give five vaccinated residents $1 million each, appears to have sparked the desired increase in new vaccinations.
What it’s like to do a human challenge trial
Human challenge trials are risky, but they could help us avoid another prolonged pandemic.
Your incentives to get the COVID-19 vaccine
If protection against a potentially deadly virus isn’t enough, there are these added incentives to get the COVID-19 vaccine.
These "Nanotraps" can capture SARS-CoV-2
Inspired by cancer cells, researchers have developed “Nanotraps” which lock up SARS-CoV-2 for the immune system to kill it.